FolioLanternBeta
IMNMImmunome Inc.

Philip Tsai

Chief Technical Officer at Immunome Inc., as of Jul 27, 2026In the past 12 months: bought $205K of stock in 1 open-market purchase.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
$205K
open-market purchases, past 12 months (1 trade)
1
company filed for

Shares held at Immunome Inc. is being verified and not shown yet. Why

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Immunome Inc. (IMNM)Chief Technical OfficerJun 18, 2024Jul 27, 2026

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.